Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to -$22.8 million.

  • Orthofix Medical's Consolidated Net Income rose 1677.01% to -$22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.1 million, marking a year-over-year increase of 481.38%. This contributed to the annual value of -$126.0 million for FY2024, which is 2000.7% up from last year.
  • According to the latest figures from Q3 2025, Orthofix Medical's Consolidated Net Income is -$22.8 million, which was up 1677.01% from -$14.1 million recorded in Q2 2025.
  • Orthofix Medical's Consolidated Net Income's 5-year high stood at $2.5 million during Q2 2022, with a 5-year trough of -$60.9 million in Q1 2023.
  • For the 5-year period, Orthofix Medical's Consolidated Net Income averaged around -$23.0 million, with its median value being -$27.4 million (2024).
  • In the last 5 years, Orthofix Medical's Consolidated Net Income skyrocketed by 11313.5% in 2021 and then crashed by 168400.96% in 2023.
  • Orthofix Medical's Consolidated Net Income (Quarter) stood at -$32.8 million in 2021, then surged by 64.42% to -$11.7 million in 2022, then crashed by 142.32% to -$28.3 million in 2023, then dropped by 3.03% to -$29.1 million in 2024, then increased by 21.79% to -$22.8 million in 2025.
  • Its Consolidated Net Income stands at -$22.8 million for Q3 2025, versus -$14.1 million for Q2 2025 and -$53.1 million for Q1 2025.